SCIENTIFIC RESOURCE COREUniversity of Rochester Paul D Wellstone MDCRC Repository and National Registry of Myotonic DystrophyPatients and Family MembersThe last 5 years have brought remarkable progress in our understanding of the disease mechanisms in themyotonic dystrophies (DM1 & DM2). A relatively complete pathophysiologic understanding of thesedisorders is within reach, and new treatments that can reverse myotonia in animal models of DM1 arealready available. To maximally exploit these research opportunities investigators need access to criticalbiological and bioinformatic resources and to patients willing to participate in clinical studies. To achievethese goals, we propose to combine our current Wellstone Center Repository Core and our NIH sponsoredNational Registry of Myotonic Dystrophy Patients and to enhance the resources of the Registry. Theresources in the Repository include DM myoblasts, transgenic mouse models and cells derived from thesemodels, plasmids for expressing expanded RNA repeats and for developing new models for repeatexpansion disorders, antibodies, and tissue samples. During the currently funded operation manyinvestigators outside of the URMC Wellstone MDCRC as well as within our Center have used Repositoryresources. A large database of information in carefully characterized DM1 patients is needed to identifyoptimal endpoints for treatment trials and develop better approaches for clinical care. To accomplish thisgoal we have included our National Registry of DM1 patients and family members which contains informationon 676 DM patients and has 6 years of annual clinical data on 70% of the patients. The Registry is a majorresource for recruitment for Project 1 in the renewal application and is a valuable resource to researcherswithin and outside of the Wellstone MDCRC network. We plan to recruit 80 Registry patients with DM1 forthe studies of Project 1. Those patients will participate in the longitudinal clinical assessments of Project 1that occur at 0, 12 and 36 months. These findings will enhance the value of their past and presentinformation in the Registry. By helping to remove barriers to research, the Registry and Repository willimprove the quality and quantity of research on DM and stimulate participation and involvement of newinvestigators, patients, family members, and care providers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54NS048843-06
Application #
7535919
Study Section
Special Emphasis Panel (ZAR1-KM-J (M1))
Project Start
2008-09-30
Project End
2013-08-30
Budget Start
2008-09-30
Budget End
2009-08-30
Support Year
6
Fiscal Year
2008
Total Cost
$52,060
Indirect Cost
Name
University of Rochester
Department
Type
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Carrell, Samuel T; Tang, Zhenzhi; Mohr, Sabine et al. (2018) Detection of expanded RNA repeats using thermostable group II intron reverse transcriptase. Nucleic Acids Res 46:e1
Trembley, Michael A; Quijada, Pearl; Agullo-Pascual, Esperanza et al. (2018) Mechanosensitive Gene Regulation by Myocardin-Related Transcription Factors Is Required for Cardiomyocyte Integrity in Load-Induced Ventricular Hypertrophy. Circulation 138:1864-1878
Auerbach, David S; Biton, Yitschak; Polonsky, Bronislava et al. (2018) Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications. Transl Res 191:81-92.e7
Sznajder, ?ukasz J; Thomas, James D; Carrell, Ellie M et al. (2018) Intron retention induced by microsatellite expansions as a disease biomarker. Proc Natl Acad Sci U S A 115:4234-4239
Wood, Libby; Bassez, Guillaume; Bleyenheuft, Corinne et al. (2018) Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease. Orphanet J Rare Dis 13:155
Jauvin, Dominic; Chrétien, Jessina; Pandey, Sanjay K et al. (2017) Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice. Mol Ther Nucleic Acids 7:465-474
Skov, Martin; Dirksen, Robert T (2017) Trojan triplets: RNA-based pathomechanisms for muscle dysfunction in Huntington's disease. J Gen Physiol 149:49-53
Pinto, Belinda S; Saxena, Tanvi; Oliveira, Ruan et al. (2017) Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9. Mol Cell 68:479-490.e5
Thornton, Charles A; Wang, Eric; Carrell, Ellie M (2017) Myotonic dystrophy: approach to therapy. Curr Opin Genet Dev 44:135-140
Gadalla, S M; Hilbert, J E; Martens, W B et al. (2017) Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy. Eur J Neurol 24:713-718

Showing the most recent 10 out of 88 publications